Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.53 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.49 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.49 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.43 |
| ▸ | IDO1 | P14902 | 1/20 | 0.42 |
| ▸ | TDO2 | P48775 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | AGER | Q15109 | 1/20 | 0.38 |
| ▸ | AOC1 | P19801 | 1/20 | 0.38 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16823551 | 0.94 | RAB9A (0.50) | RAB9AKMT2ANPC1HDAC3HDAC1 | |
| SCHEMBL3717751 | 0.90 | RAB9A (0.44) | RAB9AKMT2ANPC1HDAC3HDAC1 | |
| SCHEMBL23142643 | 0.84 | RAB9A (0.43) | RAB9AKMT2ANPC1HDAC3HDAC1 | |
| SCHEMBL23142668 | 0.84 | RAB9A (0.43) | RAB9AKMT2ANPC1HDAC3HDAC1 | |
| SCHEMBL13438637 | 0.81 | PRKCQ (0.42) | RAB9AKMT2ANPC1HDAC3HDAC1 | |
| SCHEMBL11934751 | 0.81 | PRKCQ (0.42) | RAB9AKMT2ANPC1HDAC3HDAC1 | |
| SCHEMBL22414312 | 0.81 | RAB9A (0.44) | RAB9AKMT2ANPC1SMN1; SMN2EPHX1 | |
| SCHEMBL22414314 | 0.81 | NPC1 (0.47) | RAB9AKMT2ANPC1MEN1SMN1; SMN2 | |
| SCHEMBL21799807 | 0.81 | NFE2L2 (0.46) | RAB9AKMT2AMEN1SMN1; SMN2EPHX1 | |
| SCHEMBL6884915 | 0.81 | S1PR1 (0.52) | RAB9AKMT2ANPC1MEN1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11795315-B2 | Group 5 metal complexes for producing amine-functionalized polyolefins | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2023-10-24 | — | — | US | disclosed |
| US-11795315-B2 | Group 5 metal complexes for producing amine-functionalized polyolefins | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2023-10-24 | — | — | US | disclosed |
| US-20220363786-A1 | GROUP 5 METAL COMPLEXES FOR PRODUCING AMINE-FUNTIONALIZED POLYOLEFINS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2022-11-17 | — | — | US | disclosed |
| US-20220363786-A1 | GROUP 5 METAL COMPLEXES FOR PRODUCING AMINE-FUNTIONALIZED POLYOLEFINS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2022-11-17 | — | — | US | disclosed |
| US-11034707-B2 | Group 5 metal complexes for catalytic amine functionalization | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2021-06-15 | — | — | US | disclosed |
| US-11034707-B2 | Group 5 metal complexes for catalytic amine functionalization | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2021-06-15 | — | — | US | disclosed |
| US-20200283459-A1 | GROUP 5 METAL COMPLEXES FOR CATALYTIC AMINE FUNCTIONALIZATION | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2020-09-10 | — | — | US | disclosed |
| US-20200283459-A1 | GROUP 5 METAL COMPLEXES FOR CATALYTIC AMINE FUNCTIONALIZATION | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2020-09-10 | — | — | US | disclosed |
| WO-2018213938-A1 | GROUP 5 METAL COMPLEXES FOR CATALYTIC AMINE FUNCTIONALIZATION | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2018-11-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200283459-A1 | GROUP 5 METAL COMPLEXES FOR CATALYTIC AMINE FUNCTIONALIZATION | ADH5, PRMT5, MAOA | RAB9A 1456/4885KMT2A 307/4885NPC1 3200/4885 |
| US-11034707-B2 | Group 5 metal complexes for catalytic amine functionalization | ADH5, PRMT5, MAOA | RAB9A 1456/4885KMT2A 307/4885NPC1 3200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.